It’s no secret that the COVID-19 pandemic drove a rapid increase in the adoption of decentralized clinical trials (DCTs) across the life sciences industry. Utilizing digital technologies has demonstrated ample benefits to sponsors, study teams and importantly, patients. These benefits include increasing efficiency across clinical operations and data management, simplifying the sponsor technology ecosystem, reducing patient and site burden, accelerating timelines, providing access to real-time data and insights, improving access to more diverse patient populations and more.
Now that many sponsors are embracing DCT strategies, these organizations will need to focus on scaling their approach in implementing digital capabilities to ensure long-term success and achieving a positive ROI. To achieve scale, digital strategies need to be embedded early into the pipeline of pharma and biotech companies, requiring the creation of standardized processes and an ecosystem of partners who work together to achieve a common goal.
Register for this webinar where a panel of industry experts from Medable, Syneos and Veeva will provide best practices and examples on how to successfully implement and scale patient-first DCTs across an organization to drive transformation of the clinical development process while mitigating potential risks.
(Moderator) Nicole Sheetz, Senior Director, Clinical Development Technology & Innovation, Gilead Sciences
With more than 18 years in the pharmaceutical industry and a doctorate in pharmacy, Nicole Sheetz is known for operational leadership, strategic thinking, and implementation excellence. Nicole has held leadership positions in clinical innovation, project management, data sciences, communications, data disclosure, operations, and competitor intelligence. She has spoken on behalf of TransCelerate, participated in patient-centered workshops, led speaker panels at various forums, published to advance innovation, and collaborated with biotech start-ups, CROs, specialized vendors, and advocacy groups.
Sam Bavery, Senior Director, Strategy & Growth, Medable
Sam Bavery is the Senior Director of Strategy & Growth at Medable. In this role, Sam leads the effort to scale the use of digital capabilities with Medable’s customers and partners, focusing on standardization and automation to drive cycle time reduction and increase data quality. Prior to joining Medable in 2021, Sam spent over a decade at Accenture working in roles that span across the healthcare ecosystem — with a focus on developing solutions that bridge the gap between standard of care and clinical trials. Most recently he led teams with multiple top 20 pharma companies in driving DCT strategies. Sam holds a Bachelor of Science degree in Computer Engineering from the University of Minnesota.
Juliet Hulse, Executive Director, Global RN Strategy and Patient Advocacy, Illingworth Research, a Syneos Health company
Juliet Hulse is the Executive Director of Global RN Strategy and Patient Advocacy, at Illingworth Research, a Syneos Health company. She joined the company in 2011. Juliet has over 20 years’ experience within clinical research. Commencing her career in cardiology research covering multiple Phase I-IV trials. More recently she specialised in neurology research, in the field of multiple sclerosis. Juliet has wide experience in the management of trial projects from initiation to close out as well as working with site investigators to improve patient recruitment and patient retention to study protocols. She believes that developing a strategy that places the patient in the center of the trial is vital for a successful study.
Claire Riches, Senior Vice President, Global Client Solutions, Syneos Health
Claire Riches is an industry veteran with over 25 years of experience in the clinical, pre/post approval and commercial arena. Having worked in large pharma, biotech and CRO settings, Claire currently oversees strategic partnerships at Syneos Health with a clear remit of bringing innovation and value to her clients by leveraging the full enterprise offerings of Syneos Health and the wider industry, including strategic partners. Claire is passionate about optimizing patient experience, technology offerings and ways of working to ensure clinical trial execution is optimized without sacrificing quality.
Richard Young, Vice President, Strategy Vault CDMS, Veeva
As Vice President, Strategy Vault CDMS, Richard is responsible for establishing Vault CDMS as the best in class solution for all data acquisition, management and reporting purposes. This requires the considered provision of thought leadership, developing product and market strategy, and coordinating resources across the customer life cycle. With 25 years’ experience in life sciences, Richard is known for his keen executive vision and proven operational experience in data management, eClinical Solutions, and advanced clinical strategies.
Who Should Attend?
- Clinical Operations/Development/Research
- Clinical IT/Technology
- Clinical Pharmacology
- Innovation Leads
- TA Leads
- Study/Project Management
- Data Management
- Chief Medical Officers
- Chief Scientific Officers
- Medical Affairs/Medical Liaison
What You Will Learn
- Best practices for using digital technologies (such as eConsent, eCOA, CTMS, eTMF, HHN, etc) and creating operational efficiencies in conjunction with existing processes across the product portfolio
- Examples of how shifting from a study-by-study approach to an enterprise platform approach can maximize ROI from decentralized clinical trial (DCT) technologies
- How to re-think the end-to-end process and create the right ecosystem of partners to successfully scale a DCT strategy across an organization
Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The company’s digital platform streamlines design, recruitment, retention and data quality for decentralized trials, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution. Medable connects patients, sites and clinical trial teams to improve patient access, experience, and outcomes.